In a letter signed by 30 U.S. senators, Sen. Claire McCaskill (D-Missouri) asked Kaleo Pharmaceutical to explain the 550% price hike for its Evzio opioid overdose device. The company’s product, which Kaleo sold for $690 in 2014, is priced at $4,500. Evzio is a naloxone auto-injector designed to reverse the effects of an opioid overdose. It can […]
Kaleo Inc
Kaleo announces US availability, pricing of allergy auto-injector
Kaléo Inc. said yesterday that its Auvi-Q epinephrine auto-injector will be available by prescription in the U.S. beginning Feb. 14th. The Richmond, Virginia-based company’s emergency allergy treatment was pulled from the market in 2015 due to manufacturing issues. The Epipen competitor device will be sold at a list price of $4,500, but Kaléo said that as a […]
Kaléo plans 2017 U.S. relaunch for EpiPen comptetitor Auvi-Q
Kaléo Inc. said on Wednesday that it will relaunch its Auvi-Q injector for emergency allergy treatment in the 1st half of 2017 in the U.S., according to Reuters. The Richmond, Virginia-based company’s device was recalled last year after concerns about the accuracy of delivered dose. Sanofi (NYSE:SNY) made and licensed the Auvi-Q device from Kaléo, but returned […]